| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| CD80 | CD86 | ENSPPYP00000015114 | ENSPPYP00000015088 | CD80 isoform 4. | CD86 isoform 2. | 0.986 |
| CD80 | SLC44A4 | ENSPPYP00000015114 | ENSPPYP00000018411 | CD80 isoform 4. | SLC44A4 isoform 2; Belongs to the CTL (choline transporter-like) family. | 0.687 |
| CD86 | CD80 | ENSPPYP00000015088 | ENSPPYP00000015114 | CD86 isoform 2. | CD80 isoform 4. | 0.986 |
| CD86 | SLC44A4 | ENSPPYP00000015088 | ENSPPYP00000018411 | CD86 isoform 2. | SLC44A4 isoform 2; Belongs to the CTL (choline transporter-like) family. | 0.645 |
| CLMP | SLC44A4 | ENSPPYP00000004565 | ENSPPYP00000018411 | CLMP isoform 1. | SLC44A4 isoform 2; Belongs to the CTL (choline transporter-like) family. | 0.560 |
| SLC22A1 | SLC22A2 | ENSPPYP00000019207 | ENSPPYP00000019208 | Solute carrier family 22 member 1. | Solute carrier family 22 member 2; Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline (norepinephrine), serotonin, choline, famotidine, ranitidine, histamine, creatinine, amantadine, memantine, acriflavine, 4-[4- (dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide (NMN), tetraethylammonium (TEA), 1-methyl-4- phenylpyridinium (MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as [...] | 0.924 |
| SLC22A1 | SLC22A3 | ENSPPYP00000019207 | ENSPPYP00000019210 | Solute carrier family 22 member 1. | Solute carrier family 22 member 3. | 0.907 |
| SLC22A1 | SLC22A5 | ENSPPYP00000019207 | ENSPPYP00000017626 | Solute carrier family 22 member 1. | SLC22A5 isoform 1. | 0.930 |
| SLC22A1 | SLC44A3 | ENSPPYP00000019207 | ENSPPYP00000001317 | Solute carrier family 22 member 1. | SLC44A3 isoform 1; Belongs to the CTL (choline transporter-like) family. | 0.909 |
| SLC22A1 | SLC44A4 | ENSPPYP00000019207 | ENSPPYP00000018411 | Solute carrier family 22 member 1. | SLC44A4 isoform 2; Belongs to the CTL (choline transporter-like) family. | 0.927 |
| SLC22A1 | SLC44A5 | ENSPPYP00000019207 | ENSPPYP00000001432 | Solute carrier family 22 member 1. | SLC44A5 isoform 1; Belongs to the CTL (choline transporter-like) family. | 0.915 |
| SLC22A2 | SLC22A1 | ENSPPYP00000019208 | ENSPPYP00000019207 | Solute carrier family 22 member 2; Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline (norepinephrine), serotonin, choline, famotidine, ranitidine, histamine, creatinine, amantadine, memantine, acriflavine, 4-[4- (dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide (NMN), tetraethylammonium (TEA), 1-methyl-4- phenylpyridinium (MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as [...] | Solute carrier family 22 member 1. | 0.924 |
| SLC22A2 | SLC22A3 | ENSPPYP00000019208 | ENSPPYP00000019210 | Solute carrier family 22 member 2; Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline (norepinephrine), serotonin, choline, famotidine, ranitidine, histamine, creatinine, amantadine, memantine, acriflavine, 4-[4- (dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide (NMN), tetraethylammonium (TEA), 1-methyl-4- phenylpyridinium (MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as [...] | Solute carrier family 22 member 3. | 0.924 |
| SLC22A2 | SLC22A5 | ENSPPYP00000019208 | ENSPPYP00000017626 | Solute carrier family 22 member 2; Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline (norepinephrine), serotonin, choline, famotidine, ranitidine, histamine, creatinine, amantadine, memantine, acriflavine, 4-[4- (dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide (NMN), tetraethylammonium (TEA), 1-methyl-4- phenylpyridinium (MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as [...] | SLC22A5 isoform 1. | 0.929 |
| SLC22A2 | SLC44A3 | ENSPPYP00000019208 | ENSPPYP00000001317 | Solute carrier family 22 member 2; Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline (norepinephrine), serotonin, choline, famotidine, ranitidine, histamine, creatinine, amantadine, memantine, acriflavine, 4-[4- (dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide (NMN), tetraethylammonium (TEA), 1-methyl-4- phenylpyridinium (MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as [...] | SLC44A3 isoform 1; Belongs to the CTL (choline transporter-like) family. | 0.905 |
| SLC22A2 | SLC44A4 | ENSPPYP00000019208 | ENSPPYP00000018411 | Solute carrier family 22 member 2; Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline (norepinephrine), serotonin, choline, famotidine, ranitidine, histamine, creatinine, amantadine, memantine, acriflavine, 4-[4- (dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide (NMN), tetraethylammonium (TEA), 1-methyl-4- phenylpyridinium (MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as [...] | SLC44A4 isoform 2; Belongs to the CTL (choline transporter-like) family. | 0.927 |
| SLC22A2 | SLC44A5 | ENSPPYP00000019208 | ENSPPYP00000001432 | Solute carrier family 22 member 2; Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline (norepinephrine), serotonin, choline, famotidine, ranitidine, histamine, creatinine, amantadine, memantine, acriflavine, 4-[4- (dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide (NMN), tetraethylammonium (TEA), 1-methyl-4- phenylpyridinium (MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as [...] | SLC44A5 isoform 1; Belongs to the CTL (choline transporter-like) family. | 0.915 |
| SLC22A3 | SLC22A1 | ENSPPYP00000019210 | ENSPPYP00000019207 | Solute carrier family 22 member 3. | Solute carrier family 22 member 1. | 0.907 |
| SLC22A3 | SLC22A2 | ENSPPYP00000019210 | ENSPPYP00000019208 | Solute carrier family 22 member 3. | Solute carrier family 22 member 2; Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline (norepinephrine), serotonin, choline, famotidine, ranitidine, histamine, creatinine, amantadine, memantine, acriflavine, 4-[4- (dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide (NMN), tetraethylammonium (TEA), 1-methyl-4- phenylpyridinium (MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as [...] | 0.924 |
| SLC22A3 | SLC22A5 | ENSPPYP00000019210 | ENSPPYP00000017626 | Solute carrier family 22 member 3. | SLC22A5 isoform 1. | 0.922 |